Heba Salem

432 total citations
19 papers, 332 citations indexed

About

Heba Salem is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Organic Chemistry. According to data from OpenAlex, Heba Salem has authored 19 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Organic Chemistry. Recurrent topics in Heba Salem's work include Pancreatic function and diabetes (3 papers), Synthesis and biological activity (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Heba Salem is often cited by papers focused on Pancreatic function and diabetes (3 papers), Synthesis and biological activity (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Heba Salem collaborates with scholars based in Egypt, Saudi Arabia and Germany. Heba Salem's co-authors include Bernd Baumann, Bernhard O. Boehm, Sherehan M. Ibrahim, Esraa A. Kandil, Mohamad R. Abdelaziz, Sraa Abu‐Melha, Sobhi M. Gomha, Nabila A. Kheder, Mastoura M. Edrees and Hesham I. El‐Askary and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Oncogene.

In The Last Decade

Heba Salem

18 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba Salem Egypt 10 103 92 48 44 39 19 332
Syed Hussain Basha India 10 150 1.5× 78 0.8× 19 0.4× 20 0.5× 21 0.5× 32 370
Ha-Rim Kim South Korea 13 186 1.8× 60 0.7× 18 0.4× 20 0.5× 32 0.8× 40 406
Dinesh Kumar Yadav India 11 210 2.0× 25 0.3× 60 1.3× 41 0.9× 30 0.8× 30 415
Sudeep Gautam India 12 140 1.4× 43 0.5× 20 0.4× 102 2.3× 23 0.6× 23 341
Elbert L. Myles United States 10 150 1.5× 70 0.8× 15 0.3× 19 0.4× 68 1.7× 19 441
Sivalokanathan Sarveswaran United States 10 172 1.7× 33 0.4× 30 0.6× 44 1.0× 28 0.7× 14 437
Elisa Martino Italy 15 258 2.5× 26 0.3× 25 0.5× 37 0.8× 31 0.8× 23 558
Hyuck-Se Kwon South Korea 7 215 2.1× 32 0.3× 41 0.9× 19 0.4× 65 1.7× 11 443
Tatiana Montoya Spain 13 197 1.9× 119 1.3× 17 0.4× 15 0.3× 57 1.5× 17 454
Cristina Barranquero Spain 11 133 1.3× 36 0.4× 19 0.4× 45 1.0× 43 1.1× 29 370

Countries citing papers authored by Heba Salem

Since Specialization
Citations

This map shows the geographic impact of Heba Salem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Salem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Salem more than expected).

Fields of papers citing papers by Heba Salem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba Salem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Salem. The network helps show where Heba Salem may publish in the future.

Co-authorship network of co-authors of Heba Salem

This figure shows the co-authorship network connecting the top 25 collaborators of Heba Salem. A scholar is included among the top collaborators of Heba Salem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba Salem. Heba Salem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Salem, Heba, et al.. (2024). Evaluation of community pharmacists' knowledge, practice and barriers towards diabetes management in Asir region, Saudi Arabia. Journal of Evaluation in Clinical Practice. 31(1). e14121–e14121. 5 indexed citations
3.
Ali, Asmaa, et al.. (2023). Elevation of D-dimer levels are associated with early need for mechanical ventilation support in patients with COVID-19. BMC Pulmonary Medicine. 23(1). 283–283. 4 indexed citations
4.
Sayed, Hanaa M., Mahmoud A. Ramadan, Heba Salem, & Marwa A. A. Fayed. (2023). Phytoconstituent Isolation and Cytotoxicity Evaluation of the Egyptian Cassia occidentalis L. Possessing Selective Activity against Lung Carcinoma. Journal of Chemistry. 2023. 1–11. 3 indexed citations
5.
Sayed, Hanaa M., Mahmoud A. Ramadan, Heba Salem, et al.. (2023). Phytochemical Investigation, In silico/In vivo Analgesic, and Anti-inflammatory Assessment of the Egyptian Cassia occidentalis L.. Steroids. 196. 109245–109245. 11 indexed citations
6.
Ali, Asmaa, et al.. (2023). Monocyte to eosinophil ratio as a diagnostic biomarker for overlap syndrome and predictor of disease exacerbation. International Journal of Immunopathology and Pharmacology. 37. 1200436417–1200436417. 1 indexed citations
7.
Salem, Heba, et al.. (2022). Naringenin affords protection against lipopolysaccharide/D-galactosamine-induced acute liver failure: Role of autophagy. Archives of Biochemistry and Biophysics. 717. 109121–109121. 15 indexed citations
8.
El‐Askary, Hesham I., Heba Salem, & Amira Abdel Motaal. (2022). Potential Mechanisms Involved in the Protective Effect of Dicaffeoylquinic Acids from Artemisia annua L. Leaves against Diabetes and Its Complications. Molecules. 27(3). 857–857. 16 indexed citations
9.
El‐Malah, Afaf, et al.. (2021). Design, ecofriendly synthesis, anticancer and antimicrobial screening of innovative Biginelli dihydropyrimidines using β-aroylpyruvates as synthons. Green Chemistry Letters and Reviews. 14(2). 221–233. 20 indexed citations
10.
Ibrahim, Sherehan M., et al.. (2020). Antiulcerogenic effect of melittin via mitigating TLR4/TRAF6 mediated NF-κB and p38MAPK pathways in acetic acid-induced ulcerative colitis in mice. Chemico-Biological Interactions. 331. 109276–109276. 46 indexed citations
11.
12.
Salem, Heba, Heike Neubauer, Eric J. Simon, et al.. (2019). Elevated β-cell stress levels promote severe diabetes development in mice with MODY4. Journal of Endocrinology. 244(2). 323–337. 6 indexed citations
13.
El‐Malah, Afaf, et al.. (2019). New cyclooctathienopyridine derivatives in the aim of discovering better Anti-Alzheimer's agents. Journal of Molecular Structure. 1196. 162–168. 7 indexed citations
14.
Abu‐Melha, Sraa, Mastoura M. Edrees, Heba Salem, et al.. (2019). Synthesis and Biological Evaluation of Some Novel Thiazole-Based Heterocycles as Potential Anticancer and Antimicrobial Agents. Molecules. 24(3). 539–539. 64 indexed citations
15.
Salem, Heba, et al.. (2018). Risk of Developing Second Primary Prostatic Cancer in Patients with Previously Treated Prostatic Cancer: A Retrospective Cohort Study. International Journal of Medical Research & Health Sciences. 7(11). 19–25. 2 indexed citations
17.
Salem, Heba, Katja Fiedler, Harald J. Maier, et al.. (2013). Long-Term IKK2/NF-κB Signaling in Pancreatic β-Cells Induces Immune-Mediated Diabetes. Diabetes. 63(3). 960–975. 33 indexed citations
18.
Baumann, Bernd, Heba Salem, & Bernhard O. Boehm. (2012). Anti-Inflammatory Therapy in Type 1 Diabetes. Current Diabetes Reports. 12(5). 499–509. 49 indexed citations
19.
Maier, Harald J., Martin Wagner, Tobias G. Schips, et al.. (2012). Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas. Oncogene. 32(21). 2690–2695. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026